Literature DB >> 10359044

Histological factors associated with initial bone metastasis of invasive ductal carcinoma of the breast.

T Koyama1, T Hasebe, H Tsuda, S Hirohashi, S Sasaki, T Fukutomi, S Imoto, T Umeda, K Mukai.   

Abstract

Bone is one of the most common sites of recurrence of breast cancer. Therefore, it would be clinically very useful if breast cancers with a high probability of bone metastasis (BM) could be identified by histopathological examination of the primary lesions. To elucidate histological characteristics associated with predisposition to initial BM, we examined nine histopathological parameters in the primary lesions of 110 invasive ductal carcinomas (IDCs) of the breast with 0 to 3 regional node metastases. These cases had recurrence between 4 months and 10.1 years after the initial radical surgery. The first metastatic site was bone in 24 cases, whereas other sites were involved in 86 cases. IDCs growing in a strand growth pattern or with fibrotic focus (FF) had a significantly higher frequency of initial BM than those growing in a non-strand growth pattern or without FF, respectively. Strand growth pattern was a significant predictor of the initial BM in multivariate analysis. In all 54 IDCs that developed BM during the follow-up period, osteolytic metastasis was significantly more frequent in the group with FF than in that without FF. This study demonstrated that strand growth pattern and the presence of FF are significant histopathological factors associated with initial BM. The combination of those predictive factors along with prognostic factors may provide a useful approach to identify patients at high risk for initial BM, enabling early treatment for the recurrent cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10359044      PMCID: PMC5926066          DOI: 10.1111/j.1349-7006.1999.tb00747.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  16 in total

1.  Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-beta and tumor cell factors.

Authors:  Y Morinaga; N Fujita; K Ohishi; T Tsuruo
Journal:  Int J Cancer       Date:  1997-05-02       Impact factor: 7.396

2.  Prognostic significance of accumulation of gene and chromosome alterations and histological grade in node-negative breast carcinoma.

Authors:  H Tsuda; C Sakamaki; S Tsugane; T Fukutomi; S Hirohashi
Journal:  Jpn J Clin Oncol       Date:  1998-01       Impact factor: 3.019

3.  Effects of secretory products of breast cancer cells on osteoblast-like cells.

Authors:  M Lacroix; B Siwek; J J Body
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 4.  The role of fibroblasts in tumor behavior.

Authors:  M Grégoire; B Lieubeau
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

Review 5.  Osteolytic bone metastasis in breast cancer.

Authors:  T Yoneda; A Sasaki; G R Mundy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption.

Authors:  K Ohishi; N Fujita; Y Morinaga; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

7.  Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites.

Authors:  H Tsuda; C Sakamaki; T Fukutomi; S Hirohashi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.

Authors:  T Hasebe; H Tsuda; Y Tsubono; S Imoto; K Mukai
Journal:  Jpn J Cancer Res       Date:  1997-06

9.  Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness.

Authors:  T Hasebe; H Tsuda; S Hirohashi; Y Shimosato; M Iwai; S Imoto; K Mukai
Journal:  Jpn J Cancer Res       Date:  1996-04

10.  Significance of basic fibroblast growth factor and fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast.

Authors:  T Hasebe; S Imoto; T Ogura; K Mukai
Journal:  Jpn J Cancer Res       Date:  1997-09
View more
  6 in total

1.  Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment.

Authors:  Dalit Barkan; Lara H El Touny; Aleksandra M Michalowski; Jane Ann Smith; Isabel Chu; Anne Sally Davis; Joshua D Webster; Shelley Hoover; R Mark Simpson; Jack Gauldie; Jeffrey E Green
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

Review 2.  Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.

Authors:  Dalit Barkan; Jeffrey E Green; Ann F Chambers
Journal:  Eur J Cancer       Date:  2010-03-19       Impact factor: 9.162

3.  From transformation to metastasis: deconstructing the extracellular matrix in breast cancer.

Authors:  Shelly Kaushik; Michael W Pickup; Valerie M Weaver
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

4.  C(3)1-TAg in C57BL/6 J background as a model to study mammary tumor development.

Authors:  Isadora F G Sena; Beatriz G S Rocha; Caroline C Picoli; Gabryella S P Santos; Alinne C Costa; Bryan O P Gonçalves; Ana Paula V Garcia; Maryam Soltani-Asl; Leda M C Coimbra-Campos; Walison N Silva; Pedro A C Costa; Mauro C X Pinto; Jaime H Amorim; Vasco A C Azevedo; Rodrigo R Resende; Debora Heller; Geovanni D Cassali; Akiva Mintz; Alexander Birbrair
Journal:  Histochem Cell Biol       Date:  2021-05-18       Impact factor: 4.304

5.  Characterisation of fibrosis in chemically-induced rat mammary carcinomas using multi-modal endogenous contrast MRI on a 1.5T clinical platform.

Authors:  Neil P Jerome; Jessica K R Boult; Matthew R Orton; James A d'Arcy; Ashutosh Nerurkar; Martin O Leach; Dow-Mu Koh; David J Collins; Simon P Robinson
Journal:  Eur Radiol       Date:  2017-10-16       Impact factor: 5.315

6.  Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases.

Authors:  Joanna Huszno; Elżbieta Nowara
Journal:  Prz Menopauzalny       Date:  2015-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.